KR102098691B1 - Hydrogels with controlled mechanical strengths and method for preparing thereof - Google Patents

Hydrogels with controlled mechanical strengths and method for preparing thereof Download PDF

Info

Publication number
KR102098691B1
KR102098691B1 KR1020180034560A KR20180034560A KR102098691B1 KR 102098691 B1 KR102098691 B1 KR 102098691B1 KR 1020180034560 A KR1020180034560 A KR 1020180034560A KR 20180034560 A KR20180034560 A KR 20180034560A KR 102098691 B1 KR102098691 B1 KR 102098691B1
Authority
KR
South Korea
Prior art keywords
hydrogel
collagen
monomer
artificial skin
collagen gel
Prior art date
Application number
KR1020180034560A
Other languages
Korean (ko)
Other versions
KR20190112503A (en
Inventor
정재현
신성규
정문희
한사라
조성우
Original Assignee
숭실대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 숭실대학교 산학협력단 filed Critical 숭실대학교 산학협력단
Priority to KR1020180034560A priority Critical patent/KR102098691B1/en
Publication of KR20190112503A publication Critical patent/KR20190112503A/en
Application granted granted Critical
Publication of KR102098691B1 publication Critical patent/KR102098691B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60Materials for use in artificial skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/10Hair or skin implants
    • A61F2/105Skin implants, e.g. artificial skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/362Skin, e.g. dermal papillae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52Hydrogels or hydrocolloids

Abstract

본 발명은 기계적 강도가 제어된 인공피부용 하이드로겔 및 이의 제조방법에 관한 것으로, 보다 상세하게는 콜라겐 및 단량체가 연속가교되어 다공성을 나타내는 하이드로겔은 단량체의 농도 조절을 통하여 기계적 강도가 조절될 수 있으며, 이렇게 조절된 하이드로겔의 기계적 물성은 세포가 성장, 증식 및 활동에 매우 중요한 세포 생리 조절 인자 임이 확인됨에 따라, 본 발명의 콜라겐 및 단량체가 연속가교된 콜라겐 겔은 다양한 강도의 연령별 인공피부로 제공될 수 있다.The present invention relates to a hydrogel for artificial skin having a controlled mechanical strength and a method for manufacturing the same, and more specifically, a hydrogel that exhibits porosity by continuously crosslinking collagen and monomers can be controlled by controlling the concentration of monomers. , As it is confirmed that the mechanical properties of the hydrogel adjusted as such are very important cell physiological regulatory factors for growth, proliferation and activity, the collagen gel in which the collagen and monomers of the present invention are continuously crosslinked is provided as artificial skin of various strengths according to age. Can be.

Description

기계적 강도가 제어된 인공피부용 하이드로겔 및 이의 제조방법{Hydrogels with controlled mechanical strengths and method for preparing thereof}Hydrogels with controlled mechanical strength and method for preparing thereof

본 발명은 기계적 강도가 제어된 인공피부용 하이드로겔 및 이의 제조방법을 제공한다.The present invention provides a hydrogel for artificial skin with controlled mechanical strength and a method for manufacturing the same.

피부는 인체에서 가장 큰 기관으로, 주변 독성물질과 미생물로부터 인체를 보호하고 수분 증발을 방지하는 역할을 한다. 일반적으로 인체의 피부조직은 크게 세 부분으로 나뉘어지는데, 피부의 가장 바깥쪽을 이루는 표피층과 그 아래층의 진피층, 그리로 피하조직으로 이루어진다. 이 중 표피층은 표피층과 진피층이 단단하게 결합할 수 있도록 하는 기저막(basement membrane)으로부터 여러 층으로 분화된 상피세포와 그 밖에 멜라닌세포, 면역세포로 이루어지며, 표피층 아래의 진피층은 주로 섬유아세포와 이 세포가 분비한 여러 세포외기질(extracellular matrix)로 이루어진다.The skin is the largest organ in the human body and protects the human body from surrounding toxic substances and microorganisms and prevents moisture evaporation. In general, the skin tissue of the human body is largely divided into three parts, the outermost layer of the skin and the dermis layer below it, and thus the subcutaneous tissue. Of these, the epidermal layer is composed of epithelial cells differentiated into several layers from the basement membrane that allows the epidermal layer and the dermal layer to tightly bind, and melanocytes and immune cells, and the dermal layer below the epidermal layer mainly consists of fibroblasts and these. It consists of several extracellular matrices secreted by cells.

상처를 입거나 손상된 피부는 이종조직이식(xenografts), 동종조직이식(allografts) 및 자가이식(autografts)과 같은 다양한 원천으로부터 재생된다. 그러나 항원성 및 주게의 제한적 면적등으로 인해 이와 같은 피부 대체물은 피부 재생 목적을 이루기가 용이하지 못함에 따라, 피부 조직 재생에 관한 조직공학적 접근이 요구되고 있다. Wounded or damaged skin is regenerated from a variety of sources, such as xenografts, allografts, and autografts. However, due to the antigenicity and the limited area of the crab, such a skin substitute is not easy to achieve the purpose of skin regeneration, and thus a histological approach to skin tissue regeneration is required.

조직공학에서 결정적인 인자는 구조체 제조로, 피부 재생을 유도하는 이상적인 구조체를 제조하기 위해, 생체 재로는 뛰어난 생체적합성, 적절한 마이크로구조, 조절 가능한 생분해성 및 적절한 기계적 특성을 나타내어야 한다.The decisive factor in tissue engineering is the preparation of structures, and in order to produce ideal structures that induce skin regeneration, biomaterials must exhibit excellent biocompatibility, appropriate microstructure, adjustable biodegradability and appropriate mechanical properties.

널리 이용되고 있는 피부 조직 재생용 합성 및 천연 폴리머로는 셀룰로스 유도체, 카라기난(carrageenan), 폴리아크릴산(polyacrylic acid), 폴리비닐알콜(polyvinyl alcohol), 폴리비닐피롤리돈(polyvinylpyrrolidone), 실리콘, 알지네이트 및 콜라겐 등이 있다. 특히 콜라겐은 조직공학에 있어서 가장 장래성있는 구조체 재료로, 다양한 교차결합제를 이용하여 구조체의 기계적 성질을 개선할 수 있을 뿐만 아니라, 뛰어난 생체적합성과 생분해성으로 인해 조직공학에 이용되고 있다.Cellulose derivatives, carrageenan, polyacrylic acid, polyvinyl alcohol, polyvinylpyrrolidone, silicone, alginate, and the like are widely used synthetic and natural polymers for skin tissue regeneration. Collagen and the like. In particular, collagen is the most promising structural material in tissue engineering, and is used in tissue engineering due to its excellent biocompatibility and biodegradability as well as improving the mechanical properties of the structure using various crosslinking agents.

그러나 가장 천연적인 생체재료인 알지네이트 및 실크 피브로인과 마찬가지로 콜라겐은 실온에서 가공성이 낮고 매우 높은 친수성으로 인해 직접 쾌속성형 공정(direct rapid-prototyping process)으로 제조될 경우, 정확하게 제어된 공극 구조를 갖는 입체 콜라겐 구조체를 얻기 어렵다는 문제점이 있다.However, like most natural biomaterials such as alginate and silk fibroin, collagen has low processability at room temperature and is manufactured by a direct rapid-prototyping process due to its very high hydrophilicity, resulting in a precisely controlled void structure. There is a problem that it is difficult to obtain a structure.

또한, 종래의 인공 진피 구조체는 불안정성을 나타내어 물성 제어에 어려움이 있으며, 인체 피부의 노화에 따른 모사체 제조가 불가능하다.In addition, the conventional artificial dermal structure exhibits instability, making it difficult to control physical properties, and it is impossible to manufacture a mimetic body due to aging of human skin.

대한민국공개특허 제10-2011-0032381호 (2011.03.30. 공개)Republic of Korea Patent No. 10-2011-0032381 (2011.03.30. Published)

본 발명은 정확하게 강도가 제어된 입체 콜라겐 구조체를 제공하기 위해, 콜라겐 및 단량체가 연속가교되어 다공성을 나타내는 하이드로겔을 제공하고, 상기 하이드로겔 내 진피세포를 담지시킴으로써 기계적 강도가 제어된 인공피부용 하이드로겔을 제공하고자 한다.The present invention provides a hydrogel that exhibits porosity by continuously crosslinking collagen and monomers to provide a three-dimensional collagen structure with precisely controlled strength, and hydrogel for artificial skin whose mechanical strength is controlled by supporting dermal cells in the hydrogel. Want to provide

본 발명은 콜라겐 및 단량체가 연속가교되어 다공성 기공을 가지는 하이드로겔로 이루어지고, 상기 하이드로겔 내로 진피세포가 담지되는 것을 특징으로 하는, 기계적 강도가 제어된 인공피부용 하이드로겔을 제공한다.The present invention provides a hydrogel for artificial skin with controlled mechanical strength, characterized in that collagen and monomers are continuously crosslinked to form a hydrogel having porous pores, and the dermal cells are supported in the hydrogel.

본 발명은 콜라겐 용액 및 완충 용액으로 이루어진 혼합용액을 인큐베이션하여 콜라겐 겔을 제조하는 단계(제1단계); 상기 제1단계에서 제조된 콜라겐 겔에 단량체, 가교제 및 개시제로 이루어진 혼합용액을 도포하고 인큐베이션하는 단계(제2단계); 상기 제2단계의 인큐베이션된 콜라겐 겔에 자외선을 조사하여 콜라겐과 단량체가 연속가교된 하이드로겔을 제조하는 단계(제3단계); 상기 제3단계에서 제조된 하이드로겔을 동결건조시키는 단계(제4단계); 및 상기 동결건조된 하이드로겔에 진피 세포 용액을 도포한 후 인큐베이션하는 단계(제5단계)를 포함하는 기계적 강도가 제어된 인공피부용 하이드로겔 제조방법을 제공한다.The present invention comprises the steps of preparing a collagen gel by incubating a mixed solution consisting of a collagen solution and a buffer solution (first step); Applying and incubating a mixed solution composed of a monomer, a crosslinking agent, and an initiator on the collagen gel prepared in the first step (second step); Preparing a hydrogel in which collagen and a monomer are continuously crosslinked by irradiating ultraviolet rays to the incubated collagen gel in the second step (step 3); Lyophilizing the hydrogel prepared in the third step (step 4); And applying a dermal cell solution to the lyophilized hydrogel and incubating it (step 5) to provide a method for manufacturing a hydrogel for artificial skin with controlled mechanical strength.

또한, 본 발명은 상기 인공피부용 하이드로겔을 포함하는 인공피부를 제공한다.In addition, the present invention provides an artificial skin comprising the hydrogel for artificial skin.

본 발명에 따르면, 콜라겐 및 단량체가 연속가교되어 다공성을 나타내는 하이드로겔은 단량체의 농도 조절을 통하여 기계적 강도가 조절될 수 있으며, 이렇게 조절된 하이드로겔의 기계적 물성은 세포가 성장, 증식 및 활동에 매우 중요한 세포 생리 조절 인자 임이 확인됨에 따라, 본 발명의 콜라겐 및 단량체가 연속가교된 콜라겐 겔은 다양한 강도의 연령별 인공피부로 제공될 수 있다.According to the present invention, the hydrogel exhibiting porosity by continuously crosslinking collagen and monomers can be controlled in mechanical strength by controlling the concentration of the monomers, and the mechanical properties of the hydrogels thus controlled are very good for cells to grow, proliferate, and activity. As it is confirmed that it is an important cell physiological regulation factor, the collagen gel in which the collagen and the monomer of the present invention are continuously crosslinked can be provided as artificial skins of various strengths according to age.

도 1은 연속가교를 통한 피부 진피세포 담지 콜라겐 겔의 제조과정을 나타낸 모식도이다.
도 2는 연속가교된 콜라겐 겔 내 형성된 기공을 확인한 SEM(Scanning electron microscopic) 이미지이다 (scale bars = 1.0 μM).
도 3은 단량체 및 개시제의 농도 변화에 따른 아크릴아마이드(acrylamide, AAm) 하이드로겔의 탄성률 변화 확인 결과이다.
도 4는 연속가교를 통한 하이드로겔 기반의 콜라겐 겔의 탄성률 변화를 확인한 결과이다.
도 5는 콜라겐 겔의 탄성률에 따른 세포 대사 활성을 확인한 결과이다.
도 6은 겔 강도 따른 글리코사미노글루칸(glycosaminoglycan; GAG) 합성 및 분비 수준을 확인한 결과이다.
1 is a schematic diagram showing the manufacturing process of skin dermal cell-supported collagen gel through continuous crosslinking.
2 is a SEM (Scanning electron microscopic) image confirming the pores formed in the continuously cross-linked collagen gel (scale bars = 1.0 μM).
3 is a result of confirming the change in the elastic modulus of the acrylamide (acrylamide, AAm) hydrogel according to the concentration change of the monomer and initiator.
4 is a result of confirming the change in the elastic modulus of the hydrogel-based collagen gel through continuous crosslinking.
5 is a result confirming the cell metabolic activity according to the elastic modulus of the collagen gel.
6 is a result of confirming the glycosaminoglycan (GAG) synthesis and secretion levels according to the gel strength.

이하, 본 발명을 보다 상세하게 설명한다.Hereinafter, the present invention will be described in more detail.

콜라겐 겔의 강도를 제어하기 위해서 종래에는 2가 또는 다가 알데하이드(aldehyde)를 갖는 짧은 가교제 (cross-linker)를 사용하였으나, 콜라겐 가교에 참여하지 않고 겔 안에 남아있는 알데하이드 분자단이 세포에 독성을 나타내는 문제점이 확인됨에 따라, 본 발명자들은 인체 또는 세포에 보다 안전하게 콜라겐 겔의 강도를 제어하기 위한 방법을 연구하던 중 생체 재료인 콜라겐과 단량체인 아크릴아마이드가 연속가교된 하이드로겔 기반의 콜라겐 겔을 개발하여 본 발명을 완성하였다.In order to control the strength of the collagen gel, conventionally, a short cross-linker having a divalent or polyhydric aldehyde was used, but the aldehyde molecular group remaining in the gel that does not participate in collagen crosslinking is toxic to cells. As problems were identified, the present inventors developed a hydrogel-based collagen gel in which biomaterials collagen and monomeric acrylamide were crosslinked while researching a method for more safely controlling the strength of the collagen gel in the human body or cells. The present invention has been completed.

본 발명은 콜라겐 및 단량체가 연속가교되어 다공성 기공을 가지는 하이드로겔로 이루어지고, 상기 하이드로겔 내로 진피세포가 담지되는 것을 특징으로 하는, 기계적 강도가 제어된 인공피부용 하이드로겔을 제공할 수 있다.The present invention can provide a hydrogel for artificial skin with controlled mechanical strength, characterized in that collagen and monomers are continuously crosslinked to form a hydrogel having porous pores, and the dermal cells are supported in the hydrogel.

상기 하이드로겔은 총 100 중량부에 대하여, 콜라겐 0.1 내지 1.0 중량부 및 단량체 3 내지 10 중량부를 포함할 수 있다.The hydrogel may include 0.1 to 1.0 parts by weight of collagen and 3 to 10 parts by weight of monomer with respect to 100 parts by weight in total.

보다 상세하게는 하이드로겔 100 중량부에 대하여, 콜라겐 0.6 중량부 및 단량체 3 내지 10 중량부로 포함되며, 상기 단량체의 농도에 의해 하이드로겔의 기계적 강도가 조절될 수 있다.More specifically, with respect to 100 parts by weight of the hydrogel, 0.6 parts by weight of collagen and 3 to 10 parts by weight of the monomer are included, and the mechanical strength of the hydrogel can be controlled by the concentration of the monomer.

상기 단량체는 상기 함량의 범위 이하로 포함될 경우 하이드로겔의 형태를 이루지 못하는 문제점이 야기될 수 있으며, 상기 함량의 범위 이상으로 포함될 경우 기계적 강도가 증가하여 진피 세포의 성장, 증식 및 활동에 대한 문제점이 야기될 수 있다.When the monomer is included below the range of the content, there may be a problem that does not form a hydrogel, and when included above the range of the content, the mechanical strength increases, which causes problems with the growth, proliferation and activity of dermal cells. Can be caused.

상기 단량체는 아크릴아마이드(acrylamide), N-이소프로필아크릴아마이드(N-isopropylacrylamide ), 아크릴산(acrylic acid) 및 폴리에틸렌글리콜디아크릴레이트(Poly(ethylene glycol) diacrylate)로 이루어진 군에서 선택될 수 있으나, 이에 한정되는 것은 아니다.The monomer may be selected from the group consisting of acrylamide, N-isopropylacrylamide, acrylic acid and poly (ethylene glycol) diacrylate, It is not limited.

상기 진피 세포는 1 × 104 내지 1 × 106 세포/mL의 농도로 하이드로겔에 담지될 수 있으나, 이에 한정되는 것은 아니다.The dermal cells may be supported on a hydrogel at a concentration of 1 × 10 4 to 1 × 10 6 cells / mL, but are not limited thereto.

본 발명은 콜라겐 용액 및 완충 용액으로 이루어진 혼합용액을 인큐베이션하여 콜라겐 겔을 제조하는 단계(제1단계); 상기 제1단계에서 제조된 콜라겐 겔에 단량체, 가교제 및 개시제로 이루어진 혼합용액을 도포하고 인큐베이션하는 단계(제2단계); 상기 제2단계의 인큐베이션된 콜라겐 겔에 자외선을 조사하여 콜라겐과 단량체가 연속가교된 하이드로겔을 제조하는 단계(제3단계); 상기 제3단계에서 제조된 하이드로겔을 동결건조시키는 단계(제4단계); 및 상기 동결건조된 하이드로겔에 진피 세포 용액을 도포한 후 인큐베이션하는 단계(제5단계)를 포함하는 기계적 강도가 제어된 인공피부용 하이드로겔 제조방법을 제공할 수 있다.The present invention comprises the steps of preparing a collagen gel by incubating a mixed solution consisting of a collagen solution and a buffer solution (first step); Applying and incubating a mixed solution composed of a monomer, a crosslinking agent, and an initiator on the collagen gel prepared in the first step (second step); Preparing a hydrogel in which collagen and a monomer are continuously crosslinked by irradiating ultraviolet rays to the incubated collagen gel of the second step (step 3); Lyophilizing the hydrogel prepared in the third step (step 4); And applying a dermal cell solution to the lyophilized hydrogel and incubating it (step 5) to provide a method for manufacturing a hydrogel for artificial skin with controlled mechanical strength.

상기 단량체는 콜라겐 겔 100 중량부에 대하여, 3 내지 10 중량부로 포함되며, 상기 단량체의 농도에 의해 하이드로겔의 기계적 강도가 조절될 수 있다.The monomer is contained in 3 to 10 parts by weight based on 100 parts by weight of the collagen gel, and the mechanical strength of the hydrogel can be controlled by the concentration of the monomer.

상기 단량체는 아크릴아마이드(acrylamide), N-이소프로필아크릴아마이드(N-isopropylacrylamide ), 아크릴산(acrylic acid) 및 폴리에틸렌글리콜디아크릴레이트(Poly(ethylene glycol) diacrylate)으로 이루어진 군에서 선택될 수 있다.The monomer may be selected from the group consisting of acrylamide, N-isopropylacrylamide, acrylic acid and poly (ethylene glycol) diacrylate.

상기 가교제는 메틸렌비스아크릴아마이드(N,N'-methylenebisacrylamide), 폴리에틸렌글리콜디아크릴레이트(Poly(ethylene glycol) diacrylate) 및 메타크릴 알지네이트(Methacrylic alginate)으로 이루어진 군에서 선택될 수 있다.The crosslinking agent may be selected from the group consisting of methylenebisacrylamide (N, N'-methylenebisacrylamide), polyethylene glycol diacrylate, and methacrylic alginate.

또한, 상기 제3단계의 혼합용액은 개시제를 추가로 더 포함될 수 있다.In addition, the mixed solution of the third step may further include an initiator.

상기 개시제는 이르가큐어-2959(Irgacure-2959)일 수 있으나, 이에 한정되지 않는다.The initiator may be Irgacure-2959, but is not limited thereto.

상기 제3단계는 단량체 및 가교제로 이루어진 혼합용액이 도포된 콜라겐 겔에 360 내지 379nm 자외선을 조사하여 콜라겐 내 단량체를 광중합함으로서 콜라겐과 단량체가 연속가교된 하이드로겔을 제조할 수 있다.In the third step, a hydrogel in which collagen and monomers are continuously crosslinked can be prepared by photopolymerizing a monomer in collagen by irradiating 360 to 379 nm ultraviolet rays on a collagen gel coated with a mixed solution composed of a monomer and a crosslinking agent.

상기 제4단계의 하이드로겔을 동결건조시키는 단계는 -120 내지 -125℃, 진공 조건으로 하이드로겔을 동결건조시킬 수 있다.The step of freeze-drying the hydrogel of the fourth step may be -120 to -125 ° C, and freeze-drying the hydrogel under vacuum.

상기 제5단계의 진피 세포는 1 × 104 내지 1 × 106 세포/mL의 농도로 동결건조된 하이드로겔에 도포될 수 있다.The dermal cells of the fifth step may be applied to a lyophilized hydrogel at a concentration of 1 × 10 4 to 1 × 10 6 cells / mL.

또한, 본 발명은 상기 인공피부용 하이드로겔을 포함하는 인공피부를 제공할 수 있다.In addition, the present invention can provide an artificial skin comprising the hydrogel for artificial skin.

이하, 본 발명의 이해를 돕기 위하여 실시예를 들어 상세하게 설명하기로 한다. 다만 하기의 실시예는 본 발명의 내용을 예시하는 것일 뿐 본 발명의 범위가 하기 실시예에 한정되는 것은 아니다. 본 발명의 실시예는 당업계에서 평균적인 지식을 가진 자에게 본 발명을 보다 완전하게 설명하기 위해 제공되는 것이다.Hereinafter, examples will be described in detail to help understanding of the present invention. However, the following examples are merely illustrative of the contents of the present invention, and the scope of the present invention is not limited to the following examples. The embodiments of the present invention are provided to more fully describe the present invention to those skilled in the art.

<< 실시예Example 1>  1> 연속가교된Continuous crosslinked 콜라겐 겔 제조 및 특성 확인 Collagen gel production and characterization

1. One. 연속가교된Continuous crosslinked 콜라겐 겔 제조 Collagen gel production

4℃ 저온에서 콜라겐 용액(collagen type I, 6.1 mg/ml, Advanced BioMatrix Inc., USA)에 일정량의 RES 완충용액(reconstituting buffer solution; 0.26M NaHCO3(sodiumbicarbonate), 0.2M 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) 및 0.04M NaOH)을 첨가하고 37℃에서 4시간 동안 인큐베이션하여 순수 콜라겐 겔을 제조하였다.A certain amount of RES buffer solution (0.26M NaHCO 3 (sodiumbicarbonate), 0.2M 4- (2-hydroxyethyl) in a collagen solution (collagen type I, 6.1 mg / ml, Advanced BioMatrix Inc., USA) at a low temperature of 4 ° C ) -1-piperazineethanesulfonic acid (HEPES) and 0.04M NaOH) were added and incubated at 37 ° C. for 4 hours to prepare a pure collagen gel.

하이드로겔 기반의 콜라겐 겔을 제조하기 위해, 단량체로 아크릴아마이드(acrylamide, AAm, Sigma, USA), 가교제로 메틸렌비스아크릴아마이드(N,N'-methylenebisacrylamide, MBA, Sigma) 및 개시제로 Irgacure-2959 (Sigma)를 사용하였다.To prepare a hydrogel-based collagen gel, acrylamide (acrylamide, AAm, Sigma, USA) as a monomer, methylenebisacrylamide (N, N'-methylenebisacrylamide, MBA, Sigma) as a crosslinking agent, and Irgacure-2959 (initiator) Sigma) was used.

먼저, 일정량의 콜라겐 용액과 RES 완충용액을 1.0mm 두께를 갖는 두 개의 스페이서가 놓인 석영 판에 도입하고 또 다른 석영 판으로 덮은 후, 37℃에서 30분 동안 인큐베이션하여 콜라겐 겔을 제조하였다. 이후, AAm 및 MBA 혼합액을 콜라겐 겔에 도포하고 석영 판을 덮어 3분 동안 콜라겐 섬유 사이로 충분히 스며들도록 하였다. 이때, 가교제 MBA의 농도는 0.1 %(w/v)로 고정하고 AAm의 농도를 5 내지 10% (w/v)로 다양하게 조절하였다.First, a certain amount of collagen solution and RES buffer solution were introduced into a quartz plate on which two spacers having a thickness of 1.0 mm were placed, covered with another quartz plate, and incubated at 37 ° C for 30 minutes to prepare a collagen gel. Thereafter, a mixture of AAm and MBA was applied to the collagen gel and covered with a quartz plate to allow sufficient penetration through the collagen fibers for 3 minutes. At this time, the concentration of the crosslinking agent MBA was fixed at 0.1% (w / v) and the concentration of AAm was variously adjusted to 5 to 10% (w / v).

마지막으로 365nm UV(UV lamp, Vilber Lourmat, France)를 10분 동안 조사하여 콜라겐 겔 내부에서 AAm 단량체를 광중합(photo-polymerization)함으로써, 하이드로겔 기반의 콜라겐 겔을 연속가교 방법으로 제조하였다. 이렇게 제조된 겔은 직경 8mm, 두께 1mm로 규격화하여 물성 분석 및 세포 담지 연구에 사용하였다. Finally, 365 nm UV (UV lamp, Vilber Lourmat, France) was irradiated for 10 minutes to photopolymerize AAm monomers inside the collagen gel, thereby preparing a hydrogel-based collagen gel by a continuous crosslinking method. The gel thus prepared was standardized to 8 mm in diameter and 1 mm in thickness to be used for physical property analysis and cell loading studies.

연속가교 과정을 거쳐 제조된 콜라겐 겔을 -121℃, 진공 조건에서 동결건조 하여 도 2와 같이 콜라겐 내부에 다공성 기공을 도입하였으며, 건조된 겔을 UV로 10분 동안 멸균(sterilized)시켰다.The collagen gel prepared through the continuous crosslinking process was freeze-dried at -121 ° C and vacuum conditions to introduce porous pores inside the collagen as shown in FIG. 2, and the dried gel was sterilized with UV for 10 minutes.

2. 2. 연속가교된Continuous crosslinked 콜라겐  Collagen 겔의Gel 강도확인 Strength check

상기 실시예 1과 같이 다양한 농도의 단량체를 이용하여 제조된 콜라겐 겔의 물성을 확인하기 위해, 각 콜라겐 겔의 영 탄성률(E, elastic modulus)을 변형률에 대한 응력의 비로 계산하여 각 시료마다 측정된 평균값을 확인하였다.In order to confirm the physical properties of collagen gels prepared using various concentrations of monomers as in Example 1, the Young's modulus ( E , elastic modulus) of each collagen gel was calculated as the ratio of stress to strain and measured for each sample. The average value was confirmed.

그 결과, 도 3 및 도 4와 같이 콜라겐 겔에 연속가교를 통하여 도입된 AAm 농도가 증가됨에 따라, 1.5 kPa에서 3.0 kPa까지 다양한 강도를 갖는 콜라겐 겔이 제조된 것을 확인할 수 있었다.As a result, as shown in FIGS. 3 and 4, as the AAm concentration introduced through continuous crosslinking to the collagen gel increased, it was confirmed that collagen gels having various strengths from 1.5 kPa to 3.0 kPa were prepared.

상기 결과로부터 단량체 농도 조절을 통하여 연속가교된 콜라겐 겔을 다양한 강도를 나타내는 피부 구조체로 제공될 수 있음이 확인되었다.From the above results, it was confirmed that the collagen gel continuously crosslinked through the monomer concentration control can be provided as a skin structure exhibiting various strengths.

<< 실시예Example 2>  2> 진피세포가Dermal cells 담지된Supported 콜라겐 겔 제조 및 특성 확인 Collagen gel production and characterization

1. One. 진피세포가Dermal cells 담지된Supported 콜라겐 겔 제조 Collagen gel production

실시예 1과 같이 제조된 다공성 기공이 도입된 건조 콜라겐 겔은 진피세포 용액을 빠르게 흡수하는 동시에 팽윤(swelling)하기 때문에, 진피세포를 겔 내부에 포집(encapsulation)할 수 있다. 먼저, 진피섬유아세포(human dermal fibroblasts, HDFs, Gibco, USA)응 M106 (Gibco) 배양액에 2%(v/v) LSGS (low serum growth supplement, Gibco)와 1% (v/v) 페니실린-스트렙토마이신(Penicillin-Streptomycin, P/S, Biowest, France)를 첨가하여 37℃, 5% CO2 조건에서 배양하였다. 이렇게 배양한 세포를 콜라겐 겔 용액 1 ml 당 세포 1.0 × 105 cells 농도로, 건조된 젤 위에 도포(100 μL)하여 20분간 콜라겐 겔을 빠르게 팽윤하는 동시에 겔 내부에 세포를 담지시켰다. 세포를 봉입한 콜라겐 겔은 PBS(phosphate-buffered saline, Biowest)로 2번 세척하고 LSGS 및 P/S가 첨가된 M106 배양액에서 2주 동안 37℃, 5% CO2 조건에서 배양하였다.The dried collagen gel introduced with porous pores prepared as in Example 1 absorbs the dermal cell solution rapidly and swells at the same time, so that the dermal cells can be encapsulated inside the gel. First, 2% (v / v) low serum growth supplement (LSGS) and 1% (v / v) penicillin-strepto in M106 (Gibco) culture in response to dermal fibroblasts (human dermal fibroblasts, HDFs, Gibco, USA) Mycin (Penicillin-Streptomycin, P / S, Biowest, France) was added and cultured at 37 ° C and 5% CO 2 . The cells cultured in this way were applied to the dried gel at a concentration of 1.0 × 10 5 cells per ml of the collagen gel solution (100 μL) to rapidly swell the collagen gel for 20 minutes while supporting the cells inside the gel. The collagen gel encapsulating the cells was washed twice with PBS (phosphate-buffered saline, Biowest) and incubated in 37 ° C. and 5% CO 2 conditions for 2 weeks in M106 culture solution to which LSGS and P / S were added.

2. 2. 진피세포가Dermal cells 담지된Supported 콜라겐 겔 내 세포 대사활동 수준 확인 Check the level of cellular metabolism in collagen gel

2주간의 인큐베이션 배양 후 1.5 kPa를 나타내는 콜라겐 겔에서 세포의 대사활동 수준을 기준으로하여 각각의 콜라겐 겔에서 겔 강도에 따른 세포 대사활동 수준을 표준화하였다.After 2 weeks of incubation, the level of cell metabolism in each collagen gel was standardized based on the level of cell metabolism in the collagen gel showing 1.5 kPa.

그 결과, 도 5와 같이 1.5 kPa와 비교하여 3.0 kPa의 겔에서 세포 대사활동이 약 2배 정도 감소된 것으로 확인됨에 따라, 겔의 강도가 증가할수록 세포 대사활동 수준이 감소하는 것을 확인할 수 있었다. As a result, as shown in FIG. 5, as it was confirmed that the cell metabolic activity was reduced by about 2 times in the gel of 3.0 kPa compared to 1.5 kPa, it was confirmed that the level of cellular metabolism decreased as the gel strength increased.

3. 3. 진피세포가Dermal cells 담지된Supported 콜라겐 겔 내  In collagen gel 글리코사미노글루칸Glycosamino glucan (GAG) 합성 수준 확인(GAG) Check synthesis level

콜라겐 겔 내부에서 겔 강도에 따른 세포의 글리코사미노글루칸(glycosaminoglycan; GAG) 합성 및 분비 수준을 확인하였다.The synthesis and secretion levels of glycosaminoglycan (GAG) of cells according to gel strength were confirmed inside the collagen gel.

다양한 강도의 콜라겐 겔 내부에서 세포들이 합성 및 분비한 GAG를 수준을 확인하기 위해, 각 콜라겐 겔을 알시안 블루(alcian blue)로 염색한 후, 염색 정도를 ImageJ로 분석하고 기준 GAG 농도와 비교하여, 겔 강도에 따른 상대적인 GAG 발현 수준을 각 겔의 세포수로 표준화하여 나타내었다.In order to confirm the level of GAGs synthesized and secreted by cells inside collagen gels of various strengths, each collagen gel was stained with alcian blue, and the degree of staining was analyzed with ImageJ and compared with the reference GAG concentration. , Relative GAG expression level according to gel strength was normalized to the number of cells in each gel.

그 결과, 도 5B와 같이 1.5 kPa의 강도를 갖는 순수 콜라겐 겔에서는 5×104 cells 당, 약 8.1 μg/ml의 GAG가 분비되었으나, 강도가 2배 증가한 3.0 kPa의 콜라겐 겔에서는 5×104 cells 당, 약 17.3 μg/ml로 GAG 분비량이 증가된 것을 확인할 수 있었다.As a result, as shown in FIG. 5B, in a pure collagen gel having a strength of 1.5 kPa, about 8.1 μg / ml of GAG was secreted per 5 × 10 4 cells, but in a collagen gel of 3.0 kPa whose intensity increased twice, 5 × 10 4 It was confirmed that the amount of GAG secretion was increased to about 17.3 μg / ml per cell.

앞서 확인한 도 4의 세포 증식 결과와 비교해 볼 때, 강도가 증가한 겔에서 세포 성장 및 증식은 감소되었지만 GAG 합성 및 분비는 활성화된 것을 확인할 수 있었다.Compared to the cell proliferation results of FIG. 4 identified above, it was confirmed that cell growth and proliferation were decreased in the gel with increased strength, but GAG synthesis and secretion were activated.

상기 결과들로부터 콜라겐 겔의 기계적 물성은 세포가 성장, 증식 및 활동에 매우 중요한 세포 생리 조절 인자 임을 확인할 수 있었으며, 이를 통하여 본 발명의 연속가교된 콜라겐 겔은 다양한 강도를 갖는 인공피부로 제공될 수 있음이 확인되었다.From the above results, it was confirmed that the mechanical properties of the collagen gel are very important cell physiological regulation factors for growth, proliferation and activity, and through this, the continuously crosslinked collagen gel of the present invention can be provided as artificial skin having various strengths. Yes, it was confirmed.

<< 비교예Comparative example 1> 콜라겐 용액, 완충 용액 및  1> Collagen solution, buffer solution and 하이드로겔Hydrogel 혼합용액을 이용하여  Using mixed solution 동시가교된Simultaneous crosslinked 콜라겐 젤의 특성 확인Check the properties of collagen gel

콜라겐 용액, 완충 용액 및 단량체 용액을 혼합한 혼합액을 37℃에서 30분간 인큐베이션하여 콜라겐 겔 형성을 유도하였다.The collagen gel formation was induced by incubating the mixed solution of the collagen solution, the buffer solution, and the monomer solution at 37 ° C for 30 minutes.

이후, 365nm UV를 조사하여 AAm 단량체를 광중합하여 동시가교된 하이드로겔 기반의 콜라겐 겔을 제조하였다.Then, 365nm UV was irradiated to photopolymerize the AAm monomer to prepare a hydrogel-based collagen gel that was cross-linked.

상기 실시예 2와 같은 과정으로 동결건조 후 진피세포 담지 및 배양을 수행하였다.After lyophilization in the same manner as in Example 2, dermal cell loading and culture were performed.

그 결과, 콜라겐 용액, 완충 용액 및 하이드로겔 혼합용액을 이용한 콜라겐 겔에서는 콜라겐 섬유의 형성이 잘 이루어지지 않았으며, 이는 기계적 강도는 제어할 수 있으나, 진피세포와 세포외기질 간 접착이 잘 이루어지지 않아 세포 성장, 증식 및 활동에 제한이 될 수 있다.As a result, collagen fibers were not formed well in collagen gels using collagen solution, buffer solution, and hydrogel mixed solution, which can control mechanical strength, but adhesion between dermal cells and extracellular matrix is not well achieved. May limit cell growth, proliferation and activity.

이상으로 본 발명 내용의 특정한 부분을 상세히 기술하였는 바, 당업계의 통상의 지식을 가진 자에게 있어서, 이러한 구체적 기술은 단지 바람직한 실시양태일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 명백할 것이다. 따라서 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의하여 정의된다고 할 것이다.The specific parts of the present invention have been described in detail above, and it is obvious to those skilled in the art that this specific technology is only a preferred embodiment, whereby the scope of the present invention is not limited. something to do. Therefore, the substantial scope of the present invention will be defined by the appended claims and their equivalents.

Claims (13)

콜라겐 용액 및 완충 용액으로 이루어진 혼합용액을 인큐베이션하여 콜라겐 겔을 제조하는 단계(제1단계);
상기 제1단계에서 제조된 콜라겐 겔에 단량체 및 가교제로 이루어진 혼합용액을 도포하고 인큐베이션하는 단계(제2단계);
상기 제2단계의 인큐베이션된 콜라겐 겔에 자외선을 조사하여 콜라겐과 단량체가 가교된 하이드로겔을 제조하는 단계(제3단계);
상기 제3단계에서 제조된 하이드로겔을 -120 내지 -125℃, 진공 조건으로 동결건조시켜 다공성 기공을 가지는 하이드로겔을 제조하는 단계(제4단계); 및 상기 동결건조된 하이드로겔에 진피 세포 용액을 도포한 후 인큐베이션하여 하이드로겔 내로 진피세포가 담지되는 단계(제5단계)로 제조되며, 상기 단량체가 콜라겐 겔 100 중량부에 대하여, 3 내지 10 중량부로 포함되어 단량체의 농도에 의해 하이드로겔의 기계적 강도가 조절되는 것을 특징으로 하는, 기계적 강도가 제어된 인공피부용 하이드로겔.
Preparing a collagen gel by incubating a mixed solution consisting of a collagen solution and a buffer solution (first step);
Applying a mixed solution consisting of a monomer and a crosslinking agent to the collagen gel prepared in the first step and incubating it (second step);
Preparing a hydrogel in which collagen and a monomer are crosslinked by irradiating ultraviolet rays to the incubated collagen gel in the second step (step 3);
Preparing a hydrogel having porous pores by freeze-drying the hydrogel prepared in the third step at -120 to -125 ° C in a vacuum condition (step 4); And applying the dermal cell solution to the lyophilized hydrogel, followed by incubation, whereby the dermal cells are loaded into the hydrogel (step 5), wherein the monomer is 3 to 10 weight per 100 parts by weight of the collagen gel. Hydrogel for artificial skin with mechanical strength controlled, characterized in that the mechanical strength of the hydrogel is controlled by the concentration of monomers included as a part.
청구항 1에 있어서, 상기 하이드로겔은 총 100 중량부에 대하여, 콜라겐 0.1 내지 1.0 중량부 및 단량체 3 내지 10 중량부를 포함하는 것을 특징으로 하는 인공피부용 하이드로겔.The method according to claim 1, The hydrogel is a hydrogel for artificial skin, characterized in that it contains 0.1 to 1.0 parts by weight of collagen and 3 to 10 parts by weight of monomer, based on 100 parts by weight in total. 삭제delete 청구항 1에 있어서, 상기 단량체는 아크릴아마이드(acrylamide), N-이소프로필아크릴아마이드(N-isopropylacrylamide ), 아크릴산(acrylic acid) 및 폴리에틸렌글리콜디아크릴레이트(Poly(ethylene glycol) diacrylate)으로 이루어진 군에서 선택되는 것을 특징으로 하는 인공피부용 하이드로겔.The method according to claim 1, The monomer is selected from the group consisting of acrylamide (acrylamide), N- isopropylacrylamide (N-isopropylacrylamide), acrylic acid (acrylic acid) and polyethylene glycol diacrylate (Poly (ethylene glycol) diacrylate) Hydrogel for artificial skin, characterized in that. 청구항 1에 있어서, 상기 진피 세포는 1 × 104 내지 1 × 106 세포/mL의 농도로 하이드로겔에 담지되는 것을 특징으로 하는 인공피부용 하이드로겔.The method according to claim 1, wherein the dermal cell is a hydrogel for artificial skin, characterized in that supported on a hydrogel at a concentration of 1 × 10 4 to 1 × 10 6 cells / mL. 콜라겐 용액 및 완충 용액으로 이루어진 혼합용액을 인큐베이션하여 콜라겐 겔을 제조하는 단계(제1단계);
상기 제1단계에서 제조된 콜라겐 겔에 단량체 및 가교제로 이루어진 혼합용액을 도포하고 인큐베이션하는 단계(제2단계);
상기 제2단계의 인큐베이션된 콜라겐 겔에 자외선을 조사하여 콜라겐과 단량체가 가교된 하이드로겔을 제조하는 단계(제3단계);
상기 제3단계에서 제조된 하이드로겔을 -120 내지 -125℃에서 진공 조건으로 동결건조시키는 단계(제4단계); 및 상기 동결건조된 하이드로겔에 진피 세포 용액을 도포한 후 인큐베이션하는 단계(제5단계)를 포함하며, 상기 단량체가 콜라겐 겔 100 중량부에 대하여, 3 내지 10 중량부로 포함되어 단량체의 농도에 의해 하이드로겔의 기계적 강도가 조절되는 것을 특징으로 하는 기계적 강도가 제어된 인공피부용 하이드로겔 제조방법.
Preparing a collagen gel by incubating a mixed solution consisting of a collagen solution and a buffer solution (first step);
Applying a mixed solution consisting of a monomer and a crosslinking agent to the collagen gel prepared in the first step and incubating it (second step);
Preparing a hydrogel in which collagen and a monomer are crosslinked by irradiating ultraviolet rays to the incubated collagen gel in the second step (step 3);
Lyophilizing the hydrogel prepared in the third step at -120 to -125 ° C under vacuum conditions (fourth step); And applying a dermal cell solution to the lyophilized hydrogel, followed by incubation (step 5), wherein the monomer is included in 3 to 10 parts by weight with respect to 100 parts by weight of the collagen gel, depending on the concentration of the monomer. Method for manufacturing a hydrogel for artificial skin with controlled mechanical strength, characterized in that the mechanical strength of the hydrogel is controlled.
삭제delete 청구항 6에 있어서, 상기 단량체는 아크릴아마이드(acrylamide), N-이소프로필아크릴아마이드(N-isopropylacrylamide ), 아크릴산(acrylic acid) 및 폴리에틸렌글리콜디아크릴레이트(Poly(ethylene glycol) diacrylate)으로 이루어진 군에서 선택되는 것을 특징으로 하는 기계적 강도가 제어된 인공피부용 하이드로겔 제조방법.The method according to claim 6, The monomer is selected from the group consisting of acrylamide (acrylamide), N-isopropylacrylamide (N-isopropylacrylamide), acrylic acid (acrylic acid) and polyethylene glycol diacrylate (Poly (ethylene glycol) diacrylate) Method of manufacturing a hydrogel for artificial skin with controlled mechanical strength, characterized in that. 청구항 6에 있어서, 상기 제3단계는 단량체 및 가교제로 이루어진 혼합용액이 도포된 콜라겐 겔에 360 내지 379nm 자외선을 조사하여 콜라겐 내 단량체를 광중합함으로서 콜라겐과 단량체가 가교된 하이드로겔을 제조하는 것을 특징으로 하는 기계적 강도가 제어된 인공피부용 하이드로겔 제조방법.The method according to claim 6, wherein the third step is to produce a hydrogel in which collagen and a monomer are crosslinked by photopolymerizing a monomer in collagen by irradiating 360 to 379 nm ultraviolet rays on a collagen gel coated with a mixed solution consisting of a monomer and a crosslinking agent. Method for manufacturing a hydrogel for artificial skin with controlled mechanical strength. 청구항 6에 있어서, 상기 제3단계의 혼합용액은 개시제를 추가로 더 포함하는 것을 특징으로 하는 기계적 강도가 제어된 인공피부용 하이드로겔 제조방법.The method according to claim 6, The mixed solution of the third step is a mechanical strength controlled artificial skin hydrogel manufacturing method characterized in that it further comprises an initiator. 삭제delete 청구항 6에 있어서, 상기 제5단계의 진피 세포는 1 × 104 내지 1 × 106 세포/mL의 농도로 동결건조된 하이드로겔에 도포되는 것을 특징으로 하는 기계적 강도가 제어된 인공피부용 하이드로겔 제조방법.The method according to claim 6, wherein the dermal cells of the fifth step is 1 × 10 4 to 1 × 10 6 cells / mL concentration of mechanical strength controlled artificial skin hydrogel production characterized in that applied to the lyophilized hydrogel Way. 청구항 1에 따른 인공피부용 하이드로겔을 포함하는 인공피부.Artificial skin comprising a hydrogel for artificial skin according to claim 1.
KR1020180034560A 2018-03-26 2018-03-26 Hydrogels with controlled mechanical strengths and method for preparing thereof KR102098691B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020180034560A KR102098691B1 (en) 2018-03-26 2018-03-26 Hydrogels with controlled mechanical strengths and method for preparing thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020180034560A KR102098691B1 (en) 2018-03-26 2018-03-26 Hydrogels with controlled mechanical strengths and method for preparing thereof

Publications (2)

Publication Number Publication Date
KR20190112503A KR20190112503A (en) 2019-10-07
KR102098691B1 true KR102098691B1 (en) 2020-04-08

Family

ID=68422454

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020180034560A KR102098691B1 (en) 2018-03-26 2018-03-26 Hydrogels with controlled mechanical strengths and method for preparing thereof

Country Status (1)

Country Link
KR (1) KR102098691B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102562783B1 (en) * 2022-11-18 2023-08-02 주식회사 알데바 Artificial skin and manufacturing method of an artificial skin

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008538523A (en) * 2005-04-21 2008-10-30 ザ・ボード・オブ・トラスティーズ・オブ・ザ・レランド・スタンフォード・ジュニア・ユニバーシティ Artificial cornea
KR101360942B1 (en) * 2012-10-08 2014-02-12 조선대학교산학협력단 Cell-laden biocompatible polymer-natural biocompatible material hybrid scaffold and producing method therof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101103571B1 (en) 2009-09-23 2012-01-09 한림대학교 산학협력단 Scaffold for skin tissue regeneration and artificial skin using the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008538523A (en) * 2005-04-21 2008-10-30 ザ・ボード・オブ・トラスティーズ・オブ・ザ・レランド・スタンフォード・ジュニア・ユニバーシティ Artificial cornea
KR101360942B1 (en) * 2012-10-08 2014-02-12 조선대학교산학협력단 Cell-laden biocompatible polymer-natural biocompatible material hybrid scaffold and producing method therof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102562783B1 (en) * 2022-11-18 2023-08-02 주식회사 알데바 Artificial skin and manufacturing method of an artificial skin

Also Published As

Publication number Publication date
KR20190112503A (en) 2019-10-07

Similar Documents

Publication Publication Date Title
Zhu et al. Novel enzymatic crosslinked hydrogels that mimic extracellular matrix for skin wound healing
JP4971981B2 (en) Cell-independent production of tissue equivalents
Adekogbe et al. Fabrication and characterization of DTBP-crosslinked chitosan scaffolds for skin tissue engineering
EP2089073B1 (en) Synthetic multi-layer corneal structures comprising collagen fibres
US4746514A (en) Hydrogel materials formed by radiation polymerization of carbohydrates and unsaturated monomers
Beumer et al. Cell-seeding and in vitro biocompatibility evaluation of polymeric matrices of PEO/PBT copolymers and PLLA
Woerly et al. Intracerebral implantation of synthetic polymer/biopolymer matrix: a new perspective for brain repair
KR101196365B1 (en) Interpenetrating Polymer Network Hydrogel and preparation method thereof
CN110917392A (en) Hemostatic and antibacterial hydrogel with adhesiveness and preparation method thereof
Cornwell et al. Discrete crosslinked fibrin microthread scaffolds for tissue regeneration
Gursel et al. Synthesis and mechanical properties of interpenetrating networks of polyhydroxybutyrate-co-hydroxyvalerate and polyhydroxyethyl methacrylate
WO1988008448A2 (en) Cell culture processes, materials and products
JP2014218453A (en) Collagen molded body and method for producing the same
CN114606189A (en) Acellular spinal cord-GelMA hydrogel composite material bracket for promoting proliferation and differentiation of neural stem cells
KR20080069182A (en) Shaped bodies based on a cross-linked, gelatinous material, method for producing the same and their use
CN114507364B (en) Preparation method of photo-curing casein hydrogel and application of photo-curing casein hydrogel in hemostasis and skin repair
Shi et al. Collagen/chitosan‐silicone membrane bilayer scaffold as a dermal equivalent
CN114276567A (en) Bionic hydrogel scaffold for tissue engineering skin construction and preparation method thereof
KR102098691B1 (en) Hydrogels with controlled mechanical strengths and method for preparing thereof
Nilasaroya et al. Heparin‐functionalized hydrogels as growth factor‐signaling substrates
EP3218021B1 (en) Compositions for use in a method for the prevention and/or reduction of scarring
US20210170038A1 (en) Biocampatible and Biodegradable Anionic Hydrogel System
KR102236812B1 (en) Biocompatible polymer-hydrogel complexes and preparation thereof
KR102445059B1 (en) Micropatterned nanofiber scaffold with minimal deformation
Karimi et al. Platelet-rich fibrin (PRF) gel modified by a carbodiimide crosslinker for tissue regeneration

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant